Literature DB >> 8049810

Effect of dobutamine on oxygen consumption and gastric mucosal pH in septic patients.

G Gutierrez1, C Clark, S D Brown, K Price, L Ortiz, C Nelson.   

Abstract

Decreases in gastric mucosal pH (pHi) are associated with splanchnic hypoxia in animals and with increased mortality in patients. In the present study we measured changes in gastric pHi with a tonometer in septic patients after a short-term infusion of dobutamine. These changes were compared with concurrent alterations in systemic O2 consumption (VO2) and arterial lactate. Twenty-one patients admitted sequentially to a medical intensive care unit with sepsis and gastric pHi < 7.32 were prospectively separated into a normal lactate group (< or = 2.2 mM; n = 10) and an elevated lactate group (> 2.2 mM; n = 11). Dobutamine HCl was infused intravenously at 5 micrograms/kg/min for approximately 3 h and then increased to 10 micrograms/kg/min. Measurements were obtained after each increase in the dose of dobutamine. Dobutamine infused at 10 micrograms/kg/min produced increases in O2 transport in both groups (p < 0.05) whereas systemic O2 consumption remained unchanged. These changes were accompanied by decreases in the arterial lactate concentration of the elevated lactate group (p < 0.01). Arterial lactate remained constant in the normal lactate group. Gastric pHi increased in both groups when dobutamine was infused at 5 micrograms/kg/min (p < 0.01), and then again at 10 micrograms/kg/min (p < 0.05). These results imply that regional tissue hypoxia, as characterized by a low gastric pHi, may be present in septic patients with normal arterial lactate concentration. Moreover, a rise in gastric pHi in response to increases in systemic O2 transport may be a better indicator of regional hypoxia in septic patients than related increases in systemic VO2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8049810     DOI: 10.1164/ajrccm.150.2.8049810

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

1.  Gastric intramural pH in mechanically ventilated patients.

Authors:  Z Mohsenifar; J Collier; S K Koerner
Journal:  Thorax       Date:  1996-06       Impact factor: 9.139

Review 2.  Lactic acidosis in sepsis: a commentary.

Authors:  G Gutierrez; M E Wulf
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

Review 3.  Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance.

Authors:  A Brinkmann; E Calzia; K Träger; P Radermacher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

Review 4.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Adjunctive drug treatment in severe hypoxic respiratory failure.

Authors:  S Elsasser; H Schächinger; W Strobel
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

Review 6.  [Microcirculatory monitoring of sepsis].

Authors:  A Bauer; D Bruegger; F Christ
Journal:  Anaesthesist       Date:  2005-12       Impact factor: 1.041

7.  The effects of anisodamine and dobutamine on gut mucosal blood flow during gut ischemia/ reperfusion.

Authors:  Sen Hu; Zhi-Yong Sheng
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

8.  Oxygen supply dependency can characterize septic shock.

Authors:  G Friedman; D De Backer; M Shahla; J L Vincent
Journal:  Intensive Care Med       Date:  1998-02       Impact factor: 17.440

Review 9.  Oxygen transport-the oxygen delivery controversy.

Authors:  Jean-Louis Vincent; Daniel De Backer
Journal:  Intensive Care Med       Date:  2004-07-16       Impact factor: 17.440

10.  Splanchnic oxygen transport after cardiac surgery: evidence for inadequate tissue perfusion after stabilization of hemodynamics.

Authors:  A Uusaro; E Ruokonen; J Takala
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.